Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Egyptian Pharmaceutical Journal is Scopus-indexed (Q3, CiteScore 1.5), WoS ESCI. Published by The National Centre for Information and Documentation (NIDOC), the Academy of Scientific Research and Technology, ASRT.
Checked against the index lists dated .
ISSN 1687-4315Verify ISSN ↗2090-9853Verify ISSN ↗
Publisher: The National Centre for Information and Documentation (NIDOC), the Academy of Scientific Research and Technology, ASRT
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 128 / 191 | 33rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.5.
Egyptian Pharmaceutical Journal is Q3 in Pharmaceutical Science (rank 128 of 191), by CiteScore 2025.
Egyptian Pharmaceutical Journal is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.5, which places it in quartile Q3 at the 33rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.230, quartile Q3, with an H-index of 13.
Egyptian Pharmaceutical Journal is published by The National Centre for Information and Documentation (NIDOC), the Academy of Scientific Research and Technology, ASRT. Its print ISSN is 1687-4315 and its online ISSN is 2090-9853.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Egyptian Pharmaceutical Journal has an h-index of 19 and a 2-year mean of 0.77 citations per paper (OpenAlex). Its Scopus CiteScore is 1.5, quartile Q3. On 2-year citations it ranks #118 of 177 Scopus journals in Pharmaceutical Science.
Egyptian Pharmaceutical Journal published 61 papers in 2025; its busiest recent year was 2024 with 78. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 38 research articles (2024–2026), authors are most often from Egypt (72.4%), Iraq (7.9%) and Indonesia (5.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.